Oramed Pharmaceuticals Current Ratio 2011-2025 | ORMP
Oramed Pharmaceuticals current ratio from 2011 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Oramed Pharmaceuticals Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-06-30 | $0.10B | $0.00B | 26.82 |
| 2025-03-31 | $0.13B | $0.01B | 23.94 |
| 2024-12-31 | $0.14B | $0.01B | 25.19 |
| 2024-09-30 | $0.14B | $0.01B | 27.08 |
| 2024-06-30 | $0.15B | $0.00B | 41.06 |
| 2024-03-31 | $0.18B | $0.03B | 5.28 |
| 2023-12-31 | $0.16B | $0.05B | 3.06 |
| 2023-09-30 | $0.18B | $0.08B | 2.25 |
| 2023-06-30 | $0.15B | $0.00B | 141.49 |
| 2023-03-31 | $0.16B | $0.01B | 31.21 |
| 2022-12-31 | $0.16B | $0.01B | 27.34 |
| 2022-09-30 | $0.16B | $0.01B | 24.55 |
| 2022-06-30 | $0.14B | $0.01B | 21.01 |
| 2022-03-31 | $0.14B | $0.01B | 22.70 |
| 2021-12-31 | $0.15B | $0.01B | 20.08 |
| 2021-11-30 | $0.15B | $0.01B | 19.89 |
| 2021-09-30 | $0.00B | 0.00 | |
| 2021-08-31 | $0.10B | $0.01B | 14.27 |
| 2021-06-30 | $0.00B | 0.00 | |
| 2021-05-31 | $0.07B | $0.01B | 12.56 |
| 2021-03-31 | $0.00B | 0.00 | |
| 2021-02-28 | $0.06B | $0.01B | 9.69 |
| 2020-11-30 | $0.04B | $0.01B | 6.27 |
| 2020-08-31 | $0.04B | $0.01B | 8.93 |
| 2020-05-31 | $0.04B | $0.00B | 9.99 |
| 2020-02-29 | $0.03B | $0.01B | 5.72 |
| 2019-11-30 | $0.03B | $0.01B | 6.62 |
| 2019-08-31 | $0.03B | $0.01B | 6.28 |
| 2019-05-31 | $0.03B | $0.01B | 5.10 |
| 2019-02-28 | $0.03B | $0.01B | 5.80 |
| 2018-11-30 | $0.03B | $0.00B | 7.12 |
| 2018-08-31 | $0.03B | $0.01B | 6.82 |
| 2018-05-31 | $0.02B | $0.01B | 4.18 |
| 2018-02-28 | $0.02B | $0.01B | 4.48 |
| 2017-11-30 | $0.02B | $0.01B | 3.73 |
| 2017-08-31 | $0.02B | $0.01B | 3.93 |
| 2017-05-31 | $0.03B | $0.01B | 5.23 |
| 2017-02-28 | $0.03B | $0.01B | 6.04 |
| 2016-11-30 | $0.03B | $0.01B | 6.44 |
| 2016-08-31 | $0.03B | $0.00B | 8.63 |
| 2016-05-31 | $0.03B | $0.00B | 18.79 |
| 2016-02-29 | $0.03B | $0.00B | 17.14 |
| 2015-11-30 | $0.02B | $0.00B | 11.65 |
| 2015-08-31 | $0.02B | $0.00B | 11.67 |
| 2015-05-31 | $0.02B | $0.00B | 22.62 |
| 2015-02-28 | $0.02B | $0.00B | 30.24 |
| 2014-11-30 | $0.03B | $0.00B | 29.67 |
| 2014-08-31 | $0.02B | $0.00B | 22.38 |
| 2014-05-31 | $0.02B | $0.00B | 32.26 |
| 2014-02-28 | $0.02B | $0.00B | 67.72 |
| 2013-11-30 | $0.01B | $0.00B | 11.95 |
| 2013-08-31 | $0.01B | $0.00B | 17.35 |
| 2013-05-31 | $0.01B | $0.00B | 10.82 |
| 2013-02-28 | $0.01B | $0.00B | 12.65 |
| 2012-12-31 | $0.00B | 0.00 | |
| 2012-11-30 | $0.01B | $0.00B | 20.35 |
| 2012-08-31 | $0.01B | $0.00B | 8.19 |
| 2012-05-31 | $0.00B | $0.00B | 6.91 |
| 2012-02-29 | $0.00B | $0.00B | 5.34 |
| 2011-11-30 | $0.00B | $0.00B | 9.11 |
| 2011-09-30 | $0.00B | 0.00 | |
| 2011-08-31 | $0.00B | $0.00B | 9.71 |
| 2011-06-30 | $0.00B | 0.00 | |
| 2011-05-31 | $0.00B | 0.00 | |
| 2011-03-31 | $0.00B | 0.00 | |
| 2011-02-28 | $0.00B | 0.00 | |
| 2010-12-31 | $0.00B | 0.00 | |
| 2010-11-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.090B | $0.001B |
| Oramed Pharmaceuticals, Inc. is a pharmaceutical company operating as a developer of oral drug delivery systems. The Company is developing orally ingestible insulin capsules for the treatment of diabetes as well as delivery solutions for other drugs and vaccines. Oramed Pharmaceuticals, Inc. is headquartered in Jerusalem, Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $217.272B | 25.04 |
| EssilorLuxottica (ESLOY) | France | $167.297B | 0.00 |
| Boston Scientific (BSX) | United States | $146.836B | 33.58 |
| Stryker (SYK) | United States | $135.305B | 26.86 |
| Medtronic (MDT) | Ireland | $115.519B | 16.29 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.274B | 0.00 |
| Agilent Technologies (A) | United States | $41.813B | 27.06 |
| ResMed (RMD) | United States | $36.434B | 25.22 |
| GE HealthCare Technologies (GEHC) | United States | $33.786B | 16.16 |
| Koninklijke Philips (PHG) | Netherlands | $27.193B | 17.76 |
| Terumo (TRUMY) | Japan | $23.733B | 28.12 |
| Insulet (PODD) | United States | $22.765B | 70.61 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.541B | 10.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.850B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $11.495B | 0.00 |
| Baxter (BAX) | United States | $9.243B | 7.46 |
| Bio-Rad Laboratories (BIO) | United States | $8.296B | 29.73 |
| Demant (WILYY) | Denmark | $7.359B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.651B | 10.85 |
| Haemonetics (HAE) | United States | $3.233B | 13.98 |
| Envista Holdings (NVST) | United States | $3.203B | 18.38 |
| ICU Medical (ICUI) | United States | $3.201B | 20.32 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.020B | 13.46 |
| Perrigo (PRGO) | Ireland | $2.055B | 5.15 |
| LeMaitre Vascular (LMAT) | United States | $1.938B | 39.09 |
| Phibro Animal Health (PAHC) | United States | $1.745B | 17.42 |
| Curaleaf Holdings (CURLF) | Canada | $1.634B | 0.00 |
| AtriCure (ATRC) | United States | $1.566B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.444B | 9.28 |
| Tilray Brands (TLRY) | Canada | $1.359B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.350B | 59.18 |
| Kestra Medical Technologies (KMTS) | United States | $1.343B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.300B | 18.84 |
| Neogen (NEOG) | United States | $1.299B | 24.92 |
| BioLife Solutions (BLFS) | United States | $1.294B | 386.00 |
| InMode (INMD) | Israel | $0.913B | 10.31 |
| Valneva SE (VALN) | France | $0.765B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.738B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.493B | 16.99 |
| Evolus (EOLS) | United States | $0.465B | 0.00 |
| SNDL (SNDL) | Canada | $0.462B | 0.00 |
| Omeros (OMER) | United States | $0.448B | 0.00 |
| CeriBell (CBLL) | United States | $0.429B | 0.00 |
| Surmodics (SRDX) | United States | $0.378B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.356B | 0.00 |
| Brainsway (BWAY) | Israel | $0.296B | 59.96 |
| Capricor Therapeutics (CAPR) | United States | $0.287B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.286B | 0.00 |
| Cerus (CERS) | United States | $0.270B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.261B | 0.00 |
| High Tide (HITI) | Canada | $0.253B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.248B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.245B | 145.33 |
| Owens & Minor (OMI) | United States | $0.241B | 2.42 |
| Viemed Healthcare (VMD) | United States | $0.238B | 18.97 |
| Exagen (XGN) | United States | $0.235B | 0.00 |
| Quanterix (QTRX) | United States | $0.232B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.226B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.219B | 0.00 |
| Organigram Global (OGI) | Canada | $0.199B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.189B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 16.35 |
| TerrAscend (TSNDF) | Canada | $0.181B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.176B | 21.68 |
| OraSure Technologies (OSUR) | United States | $0.172B | 0.00 |
| Biote (BTMD) | United States | $0.140B | 5.68 |
| Apyx Medical (APYX) | United States | $0.127B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.108B | 0.00 |
| Sharps Technology (STSS) | United States | $0.107B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.099B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 12.01 |
| MacroGenics (MGNX) | United States | $0.086B | 0.00 |
| Agape ATP (ATPC) | $0.062B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.057B | 33.21 |
| Nephros (NEPH) | United States | $0.055B | 40.00 |
| Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
| Jin Medical (ZJYL) | China | $0.041B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Bonk (BNKK) | United States | $0.033B | 0.00 |
| Zynex (ZYXI) | United States | $0.032B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.26 |
| Modular Medical (MODD) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| INLIF (INLF) | China | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |